Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Olsson

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Plos One|May 15, 2009
Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostateKiran Yanamandra, Oleg Alexeyev, Vladimir Zamotin, et al.
Molecular Therapy. Advances|May 15, 2026
The first oral relaxin receptor RXFP1 agonist for heart failure treatment: Translational studies from non-human primates to humansErik Ryberg, Fredrik Bergström, Sebastian Sten, et al.
Genes, Chromosomes & Cancer|January 21, 2004
Carcinogen inducibility in vivo and down-regulation of DMBT1 during breast carcinogenesisJan Mollenhauer, Burkhard Helmke, Daniel Medina, et al.
Cardiovascular Research|March 4, 2025
A novel long-acting relaxin-2 fusion, AZD3427, improves cardiac performance in non-human primates with cardiac dysfunctionMonika Papworth, Spoorthy Kulkarni, Madeleine Antonsson, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Plos One|May 15, 2009
Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostateKiran Yanamandra, Oleg Alexeyev, Vladimir Zamotin, et al.
Molecular Therapy. Advances|May 15, 2026
The first oral relaxin receptor RXFP1 agonist for heart failure treatment: Translational studies from non-human primates to humansErik Ryberg, Fredrik Bergström, Sebastian Sten, et al.
Genes, Chromosomes & Cancer|January 21, 2004
Carcinogen inducibility in vivo and down-regulation of DMBT1 during breast carcinogenesisJan Mollenhauer, Burkhard Helmke, Daniel Medina, et al.
Cardiovascular Research|March 4, 2025
A novel long-acting relaxin-2 fusion, AZD3427, improves cardiac performance in non-human primates with cardiac dysfunctionMonika Papworth, Spoorthy Kulkarni, Madeleine Antonsson, et al.
Pageof 4